№ lp_1_2_23716
File format: docx
Character count: 5578
File size: 43 KB
This document is a request form for listing inverters in compliance with UL 1741 and other relevant standards, detailing the required information for manufacturers, model specifics, safety certifications, and testing procedures.
Note:
Year
Subject:
Inverter certification and listing requests
Document Type:
Request Form
Target Audience:
Manufacturers and testing laboratories
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Subject:
Solar Energy, Photovoltaic Systems
Document Type:
Technical Plan
Target Audience:
Contractors, Engineers
Context:
Technical source document outlining standard plans for solar PV system installations for residential properties.
PumpDrive R self-cooling frequency inverter for asynchronous and synchronous motors, 27 October 2021
Year:
2021
Manufacturer:
KSB
Type:
PumpDrive R series
Document type:
Technical datasheet / Product specification
Mounting options:
Wall-mounted or cabinet-mounted
Voltage range:
3~380 V AC to 480 V AC, optional extended ranges
Frequency:
50–60 Hz ±2
Ambient conditions:
-10 °C to +50 °C, 5–95% relative humidity, non-condensing
Inputs/Outputs:
2 analog inputs, 1 analog output, 4 digital inputs, 2 relay outputs
Communication interfaces:
Modbus RTU standard, optional Profibus DP, Modbus TCP, ProfiNet, Ethernet IP, DeviceNet
Protective functions:
Overcurrent limitation, PTC monitoring, phase failure protection, motor-end short-circuit monitoring, overvoltage/undervoltage monitoring, dry running/hydraulic blockage protection
Control:
Open-loop and closed-loop operation, integrated PID controller, sensorless pressure and flow rate control
Additional features:
Programmable start/stop ramps, vector control, automatic motor adaptation, deragging function, standby mode, energy savings counter, service interface
Document status:
Typical tender, subject to technical modification
Date:
27 October 2021
Year:
2024
Region / City:
Victoria, Australia
Subject:
Solar Inverter Communication Standards
Document Type:
Ministerial Order
Organization / Institution:
Victorian Government
Author:
Victorian Government
Target Audience:
Solar inverter manufacturers, communication providers, and system integrators
Period of validity:
From 1 October 2024
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2017
Region / city:
N/A
Topic:
Battery management system, inverter interfacing
Document type:
Technical guide
Author:
N/A
Target audience:
Engineers, technicians
Effective date:
N/A
Date of approval:
N/A
Date of amendments:
N/A
Year:
N/A
Region / city:
N/A
Topic:
Power system, wind energy, inverter systems
Document type:
Technical specification
Organization:
N/A
Author:
N/A
Target audience:
Engineers, power system designers
Effective period:
N/A
Approval date:
N/A
Date of amendments:
N/A
Note:
Year
Year:
2023
Region / City:
United States
Topic:
Electrical and Mechanical Specifications for Emergency Lighting Systems
Document Type:
Technical Specification
Organization / Institution:
Trystar
Author:
Trystar
Target Audience:
Manufacturers, Engineers, and Technicians in the field of Electrical Power Systems
Period of Validity:
Ongoing
Approval Date:
N/A
Date of Amendments:
N/A
Year:
2024
Region / city:
California
Topic:
Energy / Utility Regulations
Document type:
Resolution
Organization / institution:
Public Utilities Commission of the State of California
Author:
Energy Division
Target audience:
Utilities, Industry Stakeholders, Regulatory Bodies
Effective period:
December 19, 2024
Approval date:
December 19, 2024
Amendment date:
N/A
Year:
2022
Region / city:
Yasooj, Iran
Topic:
Control of inverters, Microgrid systems, Distributed Generation
Document type:
Research Article
Organization / Institution:
Islamic Azad University, Yasooj Branch; Universitas Ahmad Dahlan; Yasouj University of Medical Sciences
Authors:
Mahmoud Zadehbagheri, Mohammad Javad Kiani, Tole Sutikno, Rasoul Arvin Moghadam
Target audience:
Engineers, researchers in electrical engineering and power systems
Period of validity:
N/A
Date of approval:
January 9, 2022
Date of revisions:
December 20, 2021
Keywords:
Backstepping Controller, Nonlinear Loads, Inverter, Lyapunov Stability, Microgrid, Distributed Generation (DG)
Document Type:
Technical Guide Specifications
Product Name:
Single Phase UL 924 Central Lighting Inverter (500 to 2700 Watts)
Equipment Type:
Floor Mount Central Lighting Inverter System (UPS)
Manufacturer:
Perfect Power, Inc.
Website:
www.perfectpower.com
Applicable Standards:
UL 1778; UL 924; FCC Part 15 Subpart J Class A; NEMA PE-1; NFPA 101; ANSI C62.41 (IEEE 587); ANSI C62.42.45 (Cat. A and B); UL 1449 4th Edition
Certification Body:
Intertek
Battery Type:
Valve Regulated Lead Acid (VRLA)
Battery Autonomy:
Minimum 90 minutes at full load (25°C)
Output Power Range:
500 to 2700 Watts
Input Frequency:
60 Hz ±4%
Output Frequency:
60 Hz ±0.5 Hz
Output Waveform:
Sinusoidal
Total Harmonic Distortion:
< 5% at full rated load
Efficiency:
Greater than 90% (typical)
Transfer Time:
Zero (no break transfer)
Protection Features:
Overload protection; short circuit protection; low battery voltage disconnect; over-temperature protection; surge protection (optional TVSS)
Communication Interfaces:
RS232; RS485; Web communication; Dry contacts
Testing Requirements:
Documented factory functional test report available upon request
Quality Assurance:
ISO 9001 certified manufacturer; minimum twenty years of UPS design and manufacturing experience
Installation Type:
Floor mount
Year:
2026
Region / City:
Chidambaram, Tamil Nadu, India
Subject:
Photovoltaic energy systems, intelligent control, battery management
Document Type:
Research paper
Institution:
Annamalai University, Department of EEE
Authors:
K. Vinoth Bresnav, Dr. S. Singaravelu
Target Audience:
Electrical engineering researchers and practitioners
Methodology:
ANN-based MPPT, bi-directional DC-DC converter, three-level NPC inverter, PI control
Simulation Environment:
MATLAB/Simulink
Key Components:
Standalone PV system, lithium-ion battery, DC link, three-phase AC load
Applications:
Off-grid renewable energy systems, dynamic load management
Performance Metrics:
MPPT efficiency, battery management effectiveness, AC output stability
Keywords:
ANN, MPPT, PV system, Bi-Directional Converter, NPC Inverter, DC Link, PI Controller
Agency:
United States Securities and Exchange Commission
Form number:
Form 25
Document type:
Regulatory filing form
Jurisdiction:
United States
Legal basis:
Securities Exchange Act of 1934
Applicable rules:
Rule 12d2-2 (17 CFR 240.12d2-2); Rule 19d-1 (17 CFR 240.19d-1)
OMB control number:
3235-0080
OMB expiration date:
March 31, 2021
Filing system:
EDGAR
Effective delisting period:
10 days after filing
Effective withdrawal of registration period:
90 days after filing
Revision identifier:
SEC 1654 (03-06)
Year:
2025
Region / city:
Australia
Subject:
Oncology, Pharmaceutical Submission
Document Type:
Pharmaceutical Benefits Scheme (PBS) Submission
Organ / Institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
JANSSEN-CILAG PTY LTD
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing
Approval Date:
Pending
Date of modifications:
N/A
Year:
2025
Region / City:
Uganda
Theme:
Procurement, Health Services, Public Contracts
Document Type:
Pre-Qualification Notice
Authority:
Mulago Specialised Women and Neonatal Hospital
Author:
Not specified
Target Audience:
Providers, Contractors, Suppliers
Period of Validity:
2025-2028
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2024
Region / Country:
Australia
Therapeutic Area:
Gastroenterology
Type of Document:
Regulatory submission / PBAC evaluation
Product:
Budesonide 4 mg suppository (Budenofalk®)
Comparator:
Budesonide 2 mg foam (Budenofalk®), prednisolone suppositories and enemas, hydrocortisone acetate enemas
Regulatory Authority:
TGA (Therapeutic Goods Administration)
Intended Use:
Short-term treatment of mild to moderate ulcerative colitis limited to the rectum
Prescriber Type:
Medical practitioners, Nurse practitioners
PBS Benefit Type:
Unrestricted
Maximum Quantity:
1 pack, 30 units
Treatment Duration:
up to 8 weeks per script
Clinical Evidence:
Phase 3, randomized, double-blind, double-dummy, non-inferiority trial (BUS-4/UCA)
Year:
2025
Region / City:
Windhoek
Subject:
Public Administration, Consultancy, Research
Document Type:
Official Announcement
Institution:
Namibia Institute of Public Administration and Management (NIPAM)
Author:
NIPAM
Target Audience:
Facilitators, Researchers, Consultants, Public Sector Experts
Period of Validity:
Until 10 February 2025
Approval Date:
Not specified
Date of Last Modification:
Not specified
Year:
2011
Regulation:
The Companies Regulations 2011, as amended
Region / Market:
Johannesburg Stock Exchange (JSE)
Document Type:
Regulatory guidance / compliance document
Scope:
Pre-Listing Statements (PLS), Revised Listing Particulars (RLP), Circulars
Language:
English
Applicable Parties:
Issuers and applicants seeking listing on JSE
Requirements:
Disclosure obligations, material contracts, corporate actions
Website Obligation:
Operational website for disclosure compliance
Audience:
Investors, shareholders
Year:
[Year]
Region / City:
Wellington
Topic:
Securities listing and quotation
Document Type:
Application
Organization:
NZ RegCo
Author:
[Issuer Name]
Target Audience:
NZX, securities issuers
Effective Period:
[Date]
Approval Date:
[Date]
Amendment Date:
[Date]
Year:
2023
Region / city:
Australia
Topic:
Oncology, Pharmaceuticals
Document Type:
Resubmission
Institution:
Australian Government, Pharmaceutical Benefits Advisory Committee
Author:
AstraZeneca Pty Ltd.
Target Audience:
Healthcare professionals, regulatory bodies
Effective Period:
Ongoing
Approval Date:
November 2021
Date of Changes:
November 2021
Note:
Year